RxDoctor Payments Data

Marvin Kalafer

Obstetrics & Gynecology · Jenkintown, PANPI 1184829723

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $386 of the $422 with a category attached, or 91.6%. Every reported general payment came from a single manufacturer, AstraZeneca.

$422in general payments, 2019–2025

Across 2 payments — averaging $210.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$422
$4,605,601in research payments, 2019–2025

Across 191 payments — averaging $24,113 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$2.9M
  • Genentech, Inc.$652K
  • Biogen$426K
  • Novartis$245K
  • Eisai Inc.$126K
  • Pfizer$124K
  • plus $112K from 6 others

What the payments were for

  • Travel & lodging$38692%
  • Food & beverage$368%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca2$422

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$422 in reported general payments places this provider in the 55th percentile of 1,711 obstetrics & gynecology providers in Pennsylvania.

See all obstetrics & gynecology providers in Pennsylvania

Other obstetrics & gynecology in Jenkintown

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →